Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$701M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$521M |
| 4 |
Humana
HUM
|
+$473M |
| 5 |
Intel
INTC
|
+$429M |
Top Sells
| 1 |
Tesla
TSLA
|
+$1.47B |
| 2 |
Meta Platforms (Facebook)
META
|
+$880M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Advanced Micro Devices
AMD
|
+$540M |
| 5 |
Caterpillar
CAT
|
+$447M |
Sector Composition
| 1 | Healthcare | 16.54% |
| 2 | Technology | 15.89% |
| 3 | Financials | 10.98% |
| 4 | Industrials | 10.72% |
| 5 | Consumer Discretionary | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
776
Allogene Therapeutics
ALLO
$255M
| $21.5M | ﹤0.01% |
4,348,503
+3,808,199
| +705% | +$18.8M |
|
777
Stem
STEM
$121M
| $21.5M | ﹤0.01% |
189,415
+171,768
| +973% | +$19.5M |
|
778
ATI
ATI
$10.4B
| $21.5M | ﹤0.01% |
543,640
+104,206
| +24% | +$4.11M |
|
779
HealthEquity
HQY
$7.92B
| $21.4M | ﹤0.01% |
364,691
+19,128
| +6% | +$1.12M |
|
780
Lithia Motors
LAD
$8.75B
| $21.4M | ﹤0.01% |
93,306
-55,227
| -37% | -$12.6M |
|
|
SPLK
781
DELISTED
Splunk Inc
SPLK
| $21.2M | ﹤0.01% |
221,399
-688,825
| -76% | -$66M |
|
782
Iovance Biotherapeutics
IOVA
$872M
| $21.2M | ﹤0.01% |
3,472,031
+1,177,989
| +51% | +$7.2M |
|
783
Factset
FDS
$13.9B
| $21.2M | ﹤0.01% |
51,070
-56,078
| -52% | -$23.3M |
|
|
XHR
784
Xenia Hotels & Resorts
XHR
$1.4B
| $21.2M | ﹤0.01% |
1,618,014
+1,522,869
| +1,601% | +$19.9M |
|
|
VIGL
785
DELISTED
Vigil Neuroscience
VIGL
| $21.2M | ﹤0.01% |
2,161,796
-2,120
| -0.1% | -$20.8K |
|
786
Healthcare Services Group
HCSG
$1.18B
| $21M | ﹤0.01% |
1,510,489
+668,127
| +79% | +$9.27M |
|
787
Avantor
AVTR
$8.85B
| $20.9M | ﹤0.01% |
989,204
-770,756
| -44% | -$16.3M |
|
788
Alnylam Pharmaceuticals
ALNY
$61.1B
| $20.9M | ﹤0.01% |
104,336
+102,896
| +7,146% | +$20.6M |
|
789
Tenet Healthcare
THC
$17.1B
| $20.8M | ﹤0.01% |
349,863
-328,354
| -48% | -$19.5M |
|
790
DHT Holdings
DHT
$1.98B
| $20.8M | ﹤0.01% |
1,920,733
-1,007,163
| -34% | -$10.9M |
|
791
Abercrombie & Fitch
ANF
$4.43B
| $20.7M | ﹤0.01% |
744,758
+351,322
| +89% | +$9.75M |
|
792
Evergy
EVRG
$16.6B
| $20.5M | ﹤0.01% |
335,520
-916,828
| -73% | -$56M |
|
793
UFP Industries
UFPI
$5.98B
| $20.5M | ﹤0.01% |
257,771
+232,800
| +932% | +$18.5M |
|
794
Liberty Global Class A
LBTYA
$4.01B
| $20.5M | ﹤0.01% |
1,049,848
-2,056,184
| -66% | -$40.1M |
|
795
Travere Therapeutics
TVTX
$2.24B
| $20.5M | ﹤0.01% |
909,999
-44,095
| -5% | -$992K |
|
796
CureVac
CVAC
$1.21B
| $20.5M | ﹤0.01% |
2,935,303
+954,433
| +48% | +$6.65M |
|
797
Liberty Global Class C
LBTYK
$4.06B
| $20.5M | ﹤0.01% |
1,003,534
-1,120,191
| -53% | -$22.8M |
|
798
Immuneering
IMRX
$345M
| $20.4M | ﹤0.01% |
2,104,653
-36,844
| -2% | -$358K |
|
799
iShares Russell 1000 Growth ETF
IWF
$120B
| $20.4M | ﹤0.01% |
83,637
+28,997
| +53% | +$7.08M |
|
800
Array Technologies
ARRY
$1.22B
| $20.3M | ﹤0.01% |
927,014
+300,571
| +48% | +$6.58M |
|